Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Nov;83(9):1147–1153. doi: 10.1054/bjoc.2000.1445

Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases

P Harvey 1, I M Clark 1, M-C Jaurand 2, R M Warn 3, D R Edwards 1
PMCID: PMC2363594  PMID: 11027427

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional factor involved both in development and tissue repair, as well as pathological processes such as cancer and metastasis. It has been identified in vivo in many types of tumours together with its tyrosine kinase receptor, Met. We show here that exogenous HGF/SF acts as a strong chemoattractant for human mesothelioma cell lines. The factor also enhanced cell adhesion to and invasion into Matrigel. The mesothelioma cell lines synthesized a panel of matrix metalloproteinases critical for tumour progression such as MMP-1, 2, 3, 9 and membrane-bound MT1-MMP. HGF/SF stimulated the expression of MMP-1, 9 and MT1-MMP and had a slight effect on expression of the MMP inhibitor TIMP-1 but not TIMP-2. However, there was no simple correlation between the levels of MMPs and TIMPs of the cell lines and their different invasion properties or between HGF/SF stimulatory effects on MMP expression and invasion. In addition, effects of protease inhibitors on invasion suggested that serine proteases were also expressed in human mesothelioma cell lines and were involved in HGF/SF-induced invasion. The results show a predominant role for HGF/SF in mesothelioma cell invasion, stimulating simultaneously adhesion, motility, invasion and regulation of MMP and TIMP levels. © 2000 Cancer Research Campaign

Keywords: HGF/SF, mesothelioma, cell motility, invasion, MMP, TIMP

Full Text

The Full Text of this article is available as a PDF (142.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan J. A., Hembry R. M., Angal S., Reynolds J. J., Murphy G. Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci. 1991 Aug;99(Pt 4):789–795. doi: 10.1242/jcs.99.4.789. [DOI] [PubMed] [Google Scholar]
  2. Attanoos R. L., Gibbs A. R. Pathology of malignant mesothelioma. Histopathology. 1997 May;30(5):403–418. doi: 10.1046/j.1365-2559.1997.5460776.x. [DOI] [PubMed] [Google Scholar]
  3. Beviglia L., Kramer R. H. HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells. Int J Cancer. 1999 Nov 26;83(5):640–649. doi: 10.1002/(sici)1097-0215(19991126)83:5<640::aid-ijc13>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  4. Bottaro D. P., Rubin J. S., Faletto D. L., Chan A. M., Kmiecik T. E., Vande Woude G. F., Aaronson S. A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991 Feb 15;251(4995):802–804. doi: 10.1126/science.1846706. [DOI] [PubMed] [Google Scholar]
  5. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. doi: 10.1083/jcb.119.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clark I. M., Powell L. K., Wright J. K., Cawston T. E., Hazleman B. L. Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix. 1992 Dec;12(6):475–480. doi: 10.1016/s0934-8832(11)80092-2. [DOI] [PubMed] [Google Scholar]
  7. Coussens L. M., Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol. 1996 Nov;3(11):895–904. doi: 10.1016/s1074-5521(96)90178-7. [DOI] [PubMed] [Google Scholar]
  8. Di Renzo M. F., Narsimhan R. P., Olivero M., Bretti S., Giordano S., Medico E., Gaglia P., Zara P., Comoglio P. M. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 1991 Nov;6(11):1997–2003. [PubMed] [Google Scholar]
  9. Dunsmore S. E., Rubin J. S., Kovacs S. O., Chedid M., Parks W. C., Welgus H. G. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem. 1996 Oct 4;271(40):24576–24582. doi: 10.1074/jbc.271.40.24576. [DOI] [PubMed] [Google Scholar]
  10. Eagles G., Warn A., Ball R. Y., Baillie-Johnson H., Arakaki N., Daikuhara Y., Warn R. M. Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Br J Cancer. 1996 Feb;73(3):377–381. doi: 10.1038/bjc.1996.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Edwards D. R., Leco K. J., Beaudry P. P., Atadja P. W., Veillette C., Riabowol K. T. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol. 1996 Jan-Apr;31(1-2):207–223. doi: 10.1016/0531-5565(95)02010-1. [DOI] [PubMed] [Google Scholar]
  12. Gherardi E., Sharpe M., Lane K., Sirulnik A., Stoker M. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells. Symp Soc Exp Biol. 1993;47:163–181. [PubMed] [Google Scholar]
  13. Grant D. S., Kleinman H. K., Goldberg I. D., Bhargava M. M., Nickoloff B. J., Kinsella J. L., Polverini P., Rosen E. M. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1937–1941. doi: 10.1073/pnas.90.5.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hamasuna R., Kataoka H., Moriyama T., Itoh H., Seiki M., Koono M. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int J Cancer. 1999 Jul 19;82(2):274–281. doi: 10.1002/(sici)1097-0215(19990719)82:2<274::aid-ijc19>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  15. Harvey P., Warn A., Dobbin S., Arakaki N., Daikuhara Y., Jaurand M. C., Warn R. M. Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology. Br J Cancer. 1998 Apr;77(7):1052–1059. doi: 10.1038/bjc.1998.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harvey P., Warn A., Newman P., Perry L. J., Ball R. Y., Warn R. M. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas. J Pathol. 1996 Dec;180(4):389–394. doi: 10.1002/(SICI)1096-9896(199612)180:4<389::AID-PATH685>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  17. Jeffers M., Rong S., Anver M., Vande Woude G. F. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Oncogene. 1996 Aug 15;13(4):853–856. [PubMed] [Google Scholar]
  18. Jeffers M., Rong S., Vande Woude G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol. 1996 Mar;16(3):1115–1125. doi: 10.1128/mcb.16.3.1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Johnson L. L., Dyer R., Hupe D. J. Matrix metalloproteinases. Curr Opin Chem Biol. 1998 Aug;2(4):466–471. doi: 10.1016/s1367-5931(98)80122-1. [DOI] [PubMed] [Google Scholar]
  20. Kheradmand F., Werner E., Tremble P., Symons M., Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science. 1998 May 8;280(5365):898–902. doi: 10.1126/science.280.5365.898. [DOI] [PubMed] [Google Scholar]
  21. Klominek J., Baskin B., Liu Z., Hauzenberger D. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor. Int J Cancer. 1998 Apr 13;76(2):240–249. doi: 10.1002/(sici)1097-0215(19980413)76:2<240::aid-ijc12>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  22. Klominek J., Sumitran Karuppan S., Hauzenberger D. Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins. Int J Cancer. 1997 Sep 17;72(6):1034–1044. doi: 10.1002/(sici)1097-0215(19970917)72:6<1034::aid-ijc19>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  23. Lohi J., Lehti K., Westermarck J., Kähäri V. M., Keski-Oja J. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem. 1996 Jul 15;239(2):239–247. doi: 10.1111/j.1432-1033.1996.0239u.x. [DOI] [PubMed] [Google Scholar]
  24. Marshall B. C., Santana A., Xu Q. P., Petersen M. J., Campbell E. J., Hoidal J. R., Welgus H. G. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest. 1993 Apr;91(4):1792–1799. doi: 10.1172/JCI116390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Messent A. J., Tuckwell D. S., Knäuper V., Humphries M. J., Murphy G., Gavrilovic J. Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion. J Cell Sci. 1998 Apr;111(Pt 8):1127–1135. doi: 10.1242/jcs.111.8.1127. [DOI] [PubMed] [Google Scholar]
  26. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem. 1993 May 15;268(14):10024–10028. [PubMed] [Google Scholar]
  27. Moriyama T., Kataoka H., Seguchi K., Tsubouchi H., Koono M. Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells. Int J Cancer. 1996 May 29;66(5):678–685. doi: 10.1002/(SICI)1097-0215(19960529)66:5<678::AID-IJC16>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  28. Murphy G., Gavrilovic J. Proteolysis and cell migration: creating a path? Curr Opin Cell Biol. 1999 Oct;11(5):614–621. doi: 10.1016/s0955-0674(99)00022-8. [DOI] [PubMed] [Google Scholar]
  29. Murphy G., Knäuper V. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol. 1997 Mar;15(8-9):511–518. doi: 10.1016/s0945-053x(97)90025-1. [DOI] [PubMed] [Google Scholar]
  30. Nakahara H., Howard L., Thompson E. W., Sato H., Seiki M., Yeh Y., Chen W. T. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7959–7964. doi: 10.1073/pnas.94.15.7959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., Comoglio P. M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 1992 Dec;11(13):4825–4833. doi: 10.1002/j.1460-2075.1992.tb05588.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Naldini L., Vigna E., Narsimhan R. P., Gaudino G., Zarnegar R., Michalopoulos G. K., Comoglio P. M. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene. 1991 Apr;6(4):501–504. [PubMed] [Google Scholar]
  33. Peacock A. J., Dawes K. E., Shock A., Gray A. J., Reeves J. T., Laurent G. J. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol. 1992 Nov;7(5):492–499. doi: 10.1165/ajrcmb/7.5.492. [DOI] [PubMed] [Google Scholar]
  34. Peto J., Hodgson J. T., Matthews F. E., Jones J. R. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995 Mar 4;345(8949):535–539. doi: 10.1016/s0140-6736(95)90462-x. [DOI] [PubMed] [Google Scholar]
  35. Prat M., Narsimhan R. P., Crepaldi T., Nicotra M. R., Natali P. G., Comoglio P. M. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer. 1991 Sep 30;49(3):323–328. doi: 10.1002/ijc.2910490302. [DOI] [PubMed] [Google Scholar]
  36. Rong S., Bodescot M., Blair D., Dunn J., Nakamura T., Mizuno K., Park M., Chan A., Aaronson S., Vande Woude G. F. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol. 1992 Nov;12(11):5152–5158. doi: 10.1128/mcb.12.11.5152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rong S., Jeffers M., Resau J. H., Tsarfaty I., Oskarsson M., Vande Woude G. F. Met expression and sarcoma tumorigenicity. Cancer Res. 1993 Nov 15;53(22):5355–5360. [PubMed] [Google Scholar]
  38. Rong S., Segal S., Anver M., Resau J. H., Vande Woude G. F. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4731–4735. doi: 10.1073/pnas.91.11.4731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rosen E. M., Knesel J., Goldberg I. D., Jin L., Bhargava M., Joseph A., Zitnik R., Wines J., Kelley M., Rockwell S. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer. 1994 Jun 1;57(5):706–714. doi: 10.1002/ijc.2910570517. [DOI] [PubMed] [Google Scholar]
  40. Shetty S., Kumar A., Johnson A., Pueblitz S., Idell S. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol. 1995 Jun;268(6 Pt 1):L972–L982. doi: 10.1152/ajplung.1995.268.6.L972. [DOI] [PubMed] [Google Scholar]
  41. Sonnenberg E., Meyer D., Weidner K. M., Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol. 1993 Oct;123(1):223–235. doi: 10.1083/jcb.123.1.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987 May 21;327(6119):239–242. doi: 10.1038/327239a0. [DOI] [PubMed] [Google Scholar]
  43. Thirkettle I., Harvey P., Hasleton P. S., Ball R. Y., Warn R. M. Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas. Histopathology. 2000 Jun;36(6):522–528. doi: 10.1046/j.1365-2559.2000.00888.x. [DOI] [PubMed] [Google Scholar]
  44. Weidner K. M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990 Nov;111(5 Pt 1):2097–2108. doi: 10.1083/jcb.111.5.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Weimar I. S., de Jong D., Muller E. J., Nakamura T., van Gorp J. M., de Gast G. C., Gerritsen W. R. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood. 1997 Feb 1;89(3):990–1000. [PubMed] [Google Scholar]
  46. Yamashita K., Suzuki M., Iwata H., Koike T., Hamaguchi M., Shinagawa A., Noguchi T., Hayakawa T. Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS Lett. 1996 Oct 28;396(1):103–107. doi: 10.1016/0014-5793(96)01066-6. [DOI] [PubMed] [Google Scholar]
  47. Zeng L., Fleury-Feith J., Monnet I., Boutin C., Bignon J., Jaurand M. C. Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum Pathol. 1994 Mar;25(3):227–234. doi: 10.1016/0046-8177(94)90192-9. [DOI] [PubMed] [Google Scholar]
  48. d'Ortho M. P., Stanton H., Butler M., Atkinson S. J., Murphy G., Hembry R. M. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett. 1998 Jan 9;421(2):159–164. doi: 10.1016/s0014-5793(97)01555-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES